Pharmadent Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 05-01-2025
- Paid Up Capital ₹ 6.52 M
as on 05-01-2025
- Company Age 27 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.02 M
as on 05-01-2025
- Satisfied Charges ₹ 4.20 M
as on 05-01-2025
- Revenue 12.99%
(FY 2021)
- Profit 167.86%
(FY 2021)
- Ebitda 51.65%
(FY 2021)
- Net Worth 17.52%
(FY 2021)
- Total Assets 25.13%
(FY 2021)
About Pharmadent Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 6.52 M.
The company currently has active open charges totaling ₹9.02 M. The company has closed loans amounting to ₹4.20 M, as per Ministry of Corporate Affairs (MCA) records.
Tasleem Karbhari and Mahmadyusuf Abdulla serve as directors at the Company.
- CIN/LLPIN
U29120GJ1997PTC105082
- Company No.
105082
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharmadent Remedies Private Limited offer?
Pharmadent Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Oral Care Products, Antiseptic Mouthwashes, Pain Relief Drugs & Pharmaceuticals, Anesthetic.
Who are the key members and board of directors at Pharmadent Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tasleem Karbhari  | Director | 05-Dec-2022 | Current |
| Mahmadyusuf Abdulla | Director | 01-Oct-2005 | Current |
Financial Performance of Pharmadent Remedies.
Pharmadent Remedies Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 12.99% increase. The company also saw a substantial improvement in profitability, with a 167.86% increase in profit. The company's net worth Soared by an impressive increase of 17.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmadent Remedies?
In 2022, Pharmadent Remedies had a public holding of 41.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Jan 2017 | ₹9.02 M | Open |
Bank Of Baroda Creation Date: 21 Nov 2014 | ₹4.20 M | Satisfied |
How Many Employees Work at Pharmadent Remedies?
Unlock and access historical data on people associated with Pharmadent Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmadent Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmadent Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
